Peripheral blood monocytes reveal an activated phenotype in pediatric uveitis

Karoline Walscheid1, Lisa Neekamp2, Arnd Heiligenhaus3

  • 1Department of Ophthalmology, Ophtha Lab, St. Franziskus-Hospital Muenster, Germany; Department of Pediatric Rheumatology and Immunology, University Hospital Muenster, Germany.

Insights

Peripheral blood monocytes in children with juvenile idiopathic arthritis and uveitis show distinct phenotypes compared to healthy controls. These changes may be influenced by treatment rather than disease activity alone.

Area of Science:

  • Immunology
  • Pediatric Rheumatology

Background:

  • Juvenile idiopathic arthritis (JIA) is a common cause of chronic childhood uveitis.
  • Understanding the immune cell profiles in JIA-associated uveitis (JIAU) is crucial for targeted therapies.

Purpose of the Study:

  • To characterize the phenotype of peripheral blood monocytes in children with JIAU.
  • To compare monocyte populations in JIAU, JIA without uveitis, idiopathic anterior uveitis (IAU), and healthy controls.

Main Methods:

  • Flow cytometry analysis of peripheral blood monocytes.
  • Inclusion of patient groups: JIA with uveitis (n=18), JIA without uveitis (n=11), IAU (n=12), and healthy controls (n=11).

Main Results:

  • Elevated CD14+CD86+ monocytes and CD86 expression in all patient groups compared to controls.
  • Increased frequency of CD39+ and CD73+ monocytes observed in patients.
  • Methotrexate treatment in JIAU patients correlated with reduced CCR2+ monocytes and increased CD86+ and CD39+ cells.

Conclusions:

  • Children with JIA or uveitis exhibit a unique monocyte phenotype.
  • Phenotypic alterations are not strictly dependent on arthritis or uveitis but can be modulated by therapeutic interventions.
Abstract